Impact of pneumococcal conjugate vaccine on infections caused by antibiotic-resistant Streptococcus pneumoniae.
about
Evolution in health and medicine Sackler colloquium: Evolution and public health.Genome-wide dissection of globally emergent multi-drug resistant serotype 19A Streptococcus pneumoniae.Ten years of surveillance for invasive Streptococcus pneumoniae during the era of antiretroviral scale-up and cotrimoxazole prophylaxis in Malawi.IDSA clinical practice guideline for acute bacterial rhinosinusitis in children and adults.Serotype distribution and antibiotic susceptibility of Streptococcus pneumoniae strains carried by children infected with human immunodeficiency virus.Serotype distribution and antimicrobial resistance of Streptococcus pneumoniae prior to introduction of the 10-valent pneumococcal conjugate vaccine in Brazil, 2000-2007Newborn vitamin A supplementation does not affect nasopharyngeal carriage of Streptococcus pneumoniae in Bangladeshi infants at age 3 months.CCL5-independent helper T lymphocyte responses to immuno-dominant pneumococcal surface protein A epitopesIn vitro activity of ceftaroline against clinical isolates of Streptococcus pneumoniae recovered in 43 U.S. medical centers during 2010-2011.Antibiotic resistance of Streptococcus pneumoniae, isolated from nasopharynx of preschool children with acute respiratory tract infection in Lithuania.Dynamics of pneumococcal nasopharyngeal carriage in healthy children attending a day care center in northern Spain. Influence of detection techniques on the resultsPediatric invasive pneumococcal disease in the United States in the era of pneumococcal conjugate vaccines.Immunogenicity and safety of a 23-valent pneumococcal polysaccharide vaccine in Chinese healthy population aged >2 years: A randomized, double-blinded, active control, phase III trialThe changing epidemiology of childhood pneumococcal disease in Korea.Why the recent ACIP recommendations regarding conjugate pneumococcal vaccine in adults may be irrelevant.Serious and invasive pediatric pneumococcal disease: epidemiology and vaccine impact in the USA.Pharmacotherapy for pneumococcal infections: an update.Pediatric head and neck complications of Streptococcus pneumoniae before and after PCV7 vaccination.Vaccine preventable meningitis in Malaysia: epidemiology and management.Transcutaneous Immunization with a Band-Aid Prevents Experimental Otitis Media in a Polymicrobial Model.Comprehensive identification of single nucleotide polymorphisms associated with beta-lactam resistance within pneumococcal mosaic genes.Distribution of serotypes and antibiotic susceptibility patterns among invasive pneumococcal diseases in Saudi Arabia.Nasopharyngeal Carriage, Capsular and Molecular Serotyping and Antimicrobial Susceptibility of Streptococcus pneumoniae among Asymptomatic Healthy Children in Egypt.Characteristics of invasive pneumococcal disease in hospitalized children in Austria.Prevention of Antibiotic-Nonsusceptible Invasive Pneumococcal Disease With the 13-Valent Pneumococcal Conjugate Vaccine.Colonizing opportunistic pathogens (COPs): The beasts in all of us.Genomic Analyses of Clonal Isolates Provide Clues to the Evolution of Streptococcus pneumoniae.Serotype distribution and antimicrobial resistance of invasive pneumococcal disease strains in the Comunidad Valenciana, Spain, during the winter of 2009-2010: low PCV7 coverage and high levofloxacin resistance.[Severe pneumococcal infections in the elderly - preventable by vaccination].Review of vaccine effectiveness assumptions used in economic evaluations of infant pneumococcal conjugate vaccine.Development of pneumococcal vaccines over the last 10 years.Serotype distribution of invasive Streptococcus pneumoniae in Canada after the introduction of the 13-valent pneumococcal conjugate vaccine, 2010–2012
P2860
Q33517441-C1F4D4FF-F898-4019-81D4-95EA0F3B26EFQ33521377-9D1E2B9C-E983-4054-AE65-C7E407FEC5A5Q33851271-865210E2-EB0D-4007-A5C4-605E8967FDD0Q34262840-5CC1F25B-A6BA-4006-B6DE-8B9B771D1E93Q34400566-1361871F-9C47-419E-BD75-D4DF065CA77AQ34516757-213E8D7E-8B28-4A25-8BA2-8EBC6E57BD36Q35217840-15F96AF0-BBBB-48D0-894A-318B153CB712Q35717991-90DE29DE-E51E-4EE3-8724-87C68A64E613Q36018756-06B40C7C-914F-4417-BE87-ED35490BBDC2Q36024311-8CE3060C-004E-4B5D-9B12-A693C20CB001Q36059360-2822B265-ADCE-408D-ADCB-38F90344C4D3Q36156085-C2B46CD3-D4B8-46AD-BA67-3307290B9C29Q36255735-FFB1BC2C-EBB8-45E2-8A54-392CE7DAA51BQ37192158-2414CA75-6E4C-49A0-94AB-1CF1769DAFEAQ37309186-5B5DEF9B-9B33-4D88-8C53-D91EBB1D9B5DQ37682905-C5F51955-2A03-4E59-BB4E-41B311554D75Q38068919-DB33F1A7-7C74-4F91-9A53-DBED791DD895Q38266840-DB2435B5-C9A4-4B45-963E-3EF6DA1CB5D0Q38472702-5B6CEAFB-82B0-4716-B3D5-0A95877CBF8EQ38851718-BC5E7A82-F1E6-4D1C-B65C-ACB3897DCBF1Q38943832-80616913-8A48-4033-B7C2-B0914ADE529BQ38960303-0957E2A1-FA55-48A9-A561-F66350106472Q38989048-2449009B-4E77-431C-ACAE-A463BE67AB03Q39343846-3FF01E1A-67F2-4BFB-9971-676DD7BA4739Q40779855-DE62311F-EE0D-43F9-AF02-28DD371AF1C2Q41346731-5389C23F-4BEC-4990-9213-D982D2902964Q41852420-29BEA633-2B2D-41CF-AE85-A3D33B2354D9Q43243681-7B753AE4-CB67-4C3E-B103-B1A44A8C68F6Q45332373-07D1CBAF-F827-4A7A-AD97-41BA31D560B2Q47429883-50586302-5F82-4166-8F86-CBBDADFDD2A2Q47658958-62BDF7A4-6988-49B4-BF41-2C235BE1382FQ57660820-AA5B23DB-480A-464D-B6E4-D8A9F329EBA9
P2860
Impact of pneumococcal conjugate vaccine on infections caused by antibiotic-resistant Streptococcus pneumoniae.
description
2009 nî lūn-bûn
@nan
2009 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Impact of pneumococcal conjuga ...... tant Streptococcus pneumoniae.
@ast
Impact of pneumococcal conjuga ...... tant Streptococcus pneumoniae.
@en
Impact of pneumococcal conjuga ...... tant Streptococcus pneumoniae.
@nl
type
label
Impact of pneumococcal conjuga ...... tant Streptococcus pneumoniae.
@ast
Impact of pneumococcal conjuga ...... tant Streptococcus pneumoniae.
@en
Impact of pneumococcal conjuga ...... tant Streptococcus pneumoniae.
@nl
prefLabel
Impact of pneumococcal conjuga ...... tant Streptococcus pneumoniae.
@ast
Impact of pneumococcal conjuga ...... tant Streptococcus pneumoniae.
@en
Impact of pneumococcal conjuga ...... tant Streptococcus pneumoniae.
@nl
P1476
Impact of pneumococcal conjuga ...... tant Streptococcus pneumoniae.
@en
P2093
P356
10.1111/J.1469-0691.2009.02726.X
P478
15 Suppl 3
P577
2009-04-01T00:00:00Z